Deepak Chemtex [DEEPAKCHEM] vs Balaji Amines [BALAMINES] Detailed Stock Comparison
Deepak Chemtex
BSE
Loading...
Balaji Amines
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Deepak Chemtex wins in 11 metrics, Balaji Amines wins in 5 metrics, with 0 ties. Deepak Chemtex appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Deepak Chemtex | Balaji Amines | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.77 | 32.71 | Deepak Chemtex |
| Price-to-Book Ratio | 2.63 | 2.70 | Deepak Chemtex |
| Debt-to-Equity Ratio | 1.62 | 0.55 | Balaji Amines |
| PEG Ratio | N/A | -1.42 | N/A |
| EV/EBITDA | 8.80 | 21.89 | Deepak Chemtex |
| Profit Margin (TTM) | 15.75% | 11.11% | Deepak Chemtex |
| Operating Margin (TTM) | 18.42% | 11.36% | Deepak Chemtex |
| EBITDA Margin (TTM) | 18.42% | 11.36% | Deepak Chemtex |
| Return on Equity | 25.74% | 7.80% | Deepak Chemtex |
| Return on Assets (TTM) | 14.75% | 6.99% | Deepak Chemtex |
| Free Cash Flow (TTM) | $-51.96M | $685.60M | Balaji Amines |
| Dividend Yield | N/A | 0.65% | N/A |
| 1-Year Return | 46.28% | -30.81% | Deepak Chemtex |
| Price-to-Sales Ratio (TTM) | 1.88 | 3.63 | Deepak Chemtex |
| Enterprise Value | $1.45B | $48.61B | Balaji Amines |
| EV/Revenue Ratio | 1.82 | 3.55 | Deepak Chemtex |
| Gross Profit Margin (TTM) | N/A | 40.84% | N/A |
| Revenue per Share (TTM) | $74 | $423 | Balaji Amines |
| Earnings per Share (Diluted) | $11.68 | $47.01 | Balaji Amines |
| Beta (Stock Volatility) | N/A | 0.61 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Deepak Chemtex vs Balaji Amines Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Deepak Chemtex | -3.03% | -12.70% | -7.72% | 32.53% | 13.64% | -1.08% |
| Balaji Amines | -0.78% | -10.07% | -20.03% | 22.44% | -8.44% | -15.64% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Deepak Chemtex | 46.28% | 17.52% | 17.52% | 17.52% | 17.52% | 17.52% |
| Balaji Amines | -30.81% | -56.73% | 114.42% | 988.95% | 3,861.87% | 5,310.27% |
Performance & Financial Health Analysis: Deepak Chemtex vs Balaji Amines
| Metric | DEEPAKCHEM | BALAMINES |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.49B | ₹49.82B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 48,160 | 86,648 |
| 90 Day Avg. Volume | 34,080 | 128,730 |
| Last Close | ₹137.50 | ₹1,521.10 |
| 52 Week Range | ₹89.00 - ₹175.00 | ₹1,127.55 - ₹2,433.00 |
| % from 52W High | -21.43% | -37.48% |
| All-Time High | ₹175.00 (Dec 16, 2024) | ₹5,223.55 (Sep 13, 2021) |
| % from All-Time High | -21.43% | -70.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.45% | -0.07% |
| Quarterly Earnings Growth | 1.40% | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.11% |
| Operating Margin (TTM) | 0.18% | 0.11% |
| Return on Equity (TTM) | 0.26% | 0.08% |
| Debt to Equity (MRQ) | 1.62 | 0.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹52.30 | ₹569.45 |
| Cash per Share (MRQ) | ₹5.35 | ₹108.10 |
| Operating Cash Flow (TTM) | ₹29.60M | ₹2.65B |
| Levered Free Cash Flow (TTM) | ₹-79,555,872 | ₹1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.65% |
| Last 12-Month Dividend | N/A | ₹11.00 |
Valuation & Enterprise Metrics Analysis: Deepak Chemtex vs Balaji Amines
| Metric | DEEPAKCHEM | BALAMINES |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.77 | 32.71 |
| Forward P/E | N/A | 20.22 |
| PEG Ratio | N/A | -1.42 |
| Price to Sales (TTM) | 1.88 | 3.63 |
| Price to Book (MRQ) | 2.63 | 2.70 |
| Market Capitalization | ||
| Market Capitalization | ₹1.49B | ₹49.82B |
| Enterprise Value | ₹1.45B | ₹48.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.82 | 3.55 |
| Enterprise to EBITDA | 8.80 | 21.89 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.61 |
| Book Value per Share (MRQ) | ₹52.30 | ₹569.45 |
Financial Statements Comparison: Deepak Chemtex vs Balaji Amines
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DEEPAKCHEM | BALAMINES |
|---|---|---|
| Revenue/Sales | N/A | ₹3.58B |
| Cost of Goods Sold | N/A | ₹2.12B |
| Gross Profit | N/A | ₹1.46B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | ₹407.22M |
| EBITDA | N/A | ₹637.15M |
| Pre-Tax Income | N/A | ₹490.13M |
| Income Tax | N/A | ₹124.86M |
| Net Income (Profit) | N/A | ₹365.27M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DEEPAKCHEM | BALAMINES |
|---|---|---|
| Cash & Equivalents | ₹56.36M | ₹1.49B |
| Total Current Assets | ₹466.21M | ₹9.41B |
| Total Current Liabilities | ₹141.63M | ₹1.30B |
| Long-Term Debt | ₹6.61M | ₹18.83M |
| Total Shareholders Equity | ₹552.52M | ₹20.18B |
| Retained Earnings | N/A | ₹16.46B |
| Property, Plant & Equipment | ₹132.52M | ₹4.14M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DEEPAKCHEM | BALAMINES |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DEEPAKCHEM | BALAMINES |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 48,160 | 86,648 |
| Average Daily Volume (90 Day) | 34,080 | 128,730 |
| Shares Outstanding | 10.86M | 32.40M |
| Float Shares | 2.84M | 9.83M |
| % Held by Insiders | 0.73% | 0.68% |
| % Held by Institutions | 0.00% | 0.03% |
Dividend Analysis & Yield Comparison: Deepak Chemtex vs Balaji Amines
| Metric | DEEPAKCHEM | BALAMINES |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹11.00 |
| Last 12-Month Dividend Yield | N/A | 0.65% |
| 3-Year Avg Annual Dividend | N/A | ₹10.67 |
| 3-Year Avg Dividend Yield | N/A | 0.51% |
| 3-Year Total Dividends | N/A | ₹32.00 |
| Ex-Dividend Date | N/A | Aug 01, 2025 |